Zhengye Biotechnology Holding Limited
ZYBTNASDAQHealthcareDrug Manufacturers - Specialty & Generic
As of Oct 16, 2026 close
- Market cap
- $71.02M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $0.62$8.01
- Volume (live)
- -
- Avg. volume (3M)
- 913.16K
Zhengye Biotechnology Holding (ZYBT) Stock Price & Financial Analysis
Zhengye Biotechnology Holding Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $1.38 - $1.57 |
|---|---|
| 52-Week High | $8.01 |
| 52-Week Low | $0.62 |
| Open | $1.50 |
| Volume (last close) | 81.28K |
| Average Volume (3M) | 913.16K |
| Revenue (TTM) | 17.40M |
|---|---|
| Net Income (TTM) | -10.44M |
| Free Cash Flow (TTM) | 105.12K |
| EPS (TTM) | −$0.22 |
| Profit Margin | -59.97% |
| Operating Margin | -58.66% |
| Return on Equity (ROE) | -27.93% |
| Debt to Equity | 0.30 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Payout Ratio | 0.00% |
| Market Cap | 71.02M |
|---|---|
| Shares Outstanding | 47.35M |
| Price to Sales (P/S) | 4.08 |
| Price to Book (P/B) | 1.90 |
| EV/EBITDA | -11.74 |
| 50-Day MA | $1.55 |
|---|---|
| 200-Day MA | $1.14 |
| 1-Year Change | −43.61% |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
Zhengye Biotechnology Holding at a Glance
As of the Oct 16, 2026 close, Zhengye Biotechnology Holding (ZYBT) has a market capitalization of $71.02M. The stock trades at 4.1× sales. Over the trailing twelve months it lost $10.44M on revenue of $17.40M and generated $105.12K of free cash flow. Revenue fell 37.6% year over year.
As of its latest reported balance sheet, it holds $7.53M in cash and securities against $11.16M of debt, a net debt position of $3.64M.
Zhengye Biotechnology Holding does not currently pay a dividend.
The share price is down 43.6% over the past year. At $1.40 (the Oct 16, 2026 close) it sits near the bottom of its 52-week range of $0.62 to $8.01, above its 200-day moving average of $1.14.
Frequently Asked Questions About Zhengye Biotechnology Holding
What is the current stock price for ZYBT?
As of the Oct 16, 2026 close, ZYBT stock trades at $1.40. The 52-week range is $0.62–$8.01, with a day range of $1.38–$1.57.
What is the P/E ratio for ZYBT?
The P/E ratio (Price-to-Earnings) for ZYBT is shown in the Key Statistics section. This valuation metric helps compare Zhengye Biotechnology Holding Limited to industry peers.
Does ZYBT pay dividends?
Zhengye Biotechnology Holding does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for ZYBT?
Analyst ratings and recommendations for ZYBT are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of ZYBT?
As of the Oct 16, 2026 close, Zhengye Biotechnology Holding's market capitalization is $66.3M, classifying it as a micro-cap company. Zhengye Biotechnology Holding operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry.